Nimbus Therapeutics said Wednesday it has raised $210 million in venture capital...
Novartis is losing its chief commercial officer, Marie-France Tschudin, who has ...
“Here's a radical idea: What if medical school was a healing experience rather t...
I tried an untested a DIY therapy, and it worked.
To be a physician who performs abortions in a small southern town is to be in a ...
"If we wanted to, this could be the last pandemic. It's a political choice,” sai...
The recently approved RSV vaccines have been celebrated as key public health too...
In the latest edition of STAT's Health Tech newsletter: Cataloging generative AI...
Novartis sued in an attempt to halt Medicare drug-price negotiations, which incl...
Illumina, the largest maker of DNA-sequencing technology, named Jacob Thaysen of...
Lawmakers are likely to extend government funding later this month, but other he...
In general, the Republican presidential candidates have done little to tout thei...
Pascal Soriot: “Of course, we are here to bring medicines to patients as quickly...
“How we scale and bring the promise of cell therapy to more patients is really, ...
DOAC use may not be approved in VTE cancer patients, but GlobalData KOLs share t...
The Series C funding will support the clinical advancement of Vega Therapeutics’...
